Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.43 |
| ▸ | MAOA | P21397 | 2/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | PDE4A | P27815 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29416115 | 1.00 | CYP1A2 (0.43) | CYP1A2CYP3A4MAOACYP2A6CYP2D6 | |
| SCHEMBL18309822 | 0.74 | CYP3A4 (0.43) | CYP1A2CYP3A4MAOACYP2A6CYP2D6 | |
| SCHEMBL23418616 | 0.71 | CYP3A4 (0.50) | CYP1A2CYP3A4MAOACYP2A6CYP2D6 | |
| SCHEMBL9099368 | 0.70 | CYP1A1 (0.38) | CYP1A2MAOAMAOBCYP1A1 | |
| SCHEMBL30098731 | 0.69 | KDM4E (0.42) | CYP3A4MAPK1KDM4EPOLBMAPT | |
| SCHEMBL9112587 | 0.66 | CYP2B6 (0.39) | CYP1A2MAOACYP1A1KDM4EHPGD | |
| SCHEMBL30593802 | 0.63 | STS (0.38) | CYP1A2CYP3A4MAOACYP2A6CYP2D6 | |
| SCHEMBL28445449 | 0.63 | CA12 (0.34) | CYP1A2CYP3A4CYP2A6CYP2D6MAPK1 | |
| SCHEMBL9394497 | 0.63 | STS (0.38) | CYP1A2CYP3A4MAOACYP2A6CYP2D6 | |
| SCHEMBL9113863 | 0.62 | STS (0.38) | CYP1A2MAOACYP2A6MAPK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240150452-A1 | MULTIFUNCTIONAL PROTEIN MOLECULES COMPRISING DECORIN AND USE THEREOF | CATALENT PHARMA SOLUTIONS, LLC | 2024-05-09 | — | — | US | disclosed |
| US-11879009-B2 | Multifunctional protein molecules comprising decorin and use thereof | CATALENT PHARMA SOLUTIONS, LLC (US) | 2024-01-23 | — | — | US | disclosed |
| US-11377488-B2 | Multifunctional protein molecules comprising decorin and use thereof | CATALENT PHARMA SOLUTIONS, LLC (US) | 2022-07-05 | — | — | US | disclosed |
| US-20210251897-A9 | NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS | NORTHWESTERN UNIVERSITY | 2021-08-19 | — | — | US | disclosed |
| US-20200214980-A1 | NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS | UNIV NORTHWESTERN (US) | 2020-07-09 | — | — | US | disclosed |
| US-20170000859-A1 | NON-NATURAL RIBONUCLEASE CONJUGATES AS CYTOTOXIC AGENTS | QUINTESSENCE BIOSCIENCES | 2017-01-05 | — | — | US | disclosed |
| US-9393319-B2 | Non-natural ribonuclease conjugates as cytotoxic agents | QUINTESSENCE BIOSCIENCES, INC. (US) | 2016-07-19 | — | — | US | disclosed |
| US-20150238575-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | QUINTESSENCE BIOSCIENCES, INC. | 2015-08-27 | — | — | US | disclosed |
| US-20140220115-A1 | NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS | NORTHWESTERN UNIVERSITY (US) | 2014-08-07 | — | — | US | disclosed |
| US-20140212946-A1 | NON-NATURAL RIBONUCLEASE CONJUGATES AS CYTOTOXIC AGENTS | QUINTESSENCE BIOSCIENCES, INC. (US) | 2014-07-31 | — | — | US | disclosed |
| US-8697065-B2 | Non-natural ribonuclease conjugates as cytotoxic agents | QUINTESSENCE BIOSCIENCES, INC. (US) | 2014-04-15 | — | — | US | disclosed |
| US-20140017241-A1 | NON-NATURAL RIBONUCLEASE CONJUGATES AS CYTOTOXIC AGENTS | QUINTESSENCE BIOSCIENCES, INC. (US) | 2014-01-16 | — | — | US | disclosed |
| US-8470315-B2 | Non-natural ribonuclease conjugates as cytotoxic agents | QUINTESSENCE BIOSCIENCES, INC. (US) | 2013-06-25 | — | — | US | disclosed |
| US-20110020434-A1 | NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-01-27 | — | — | US | disclosed |
| US-20050261232-A1 | Non-natural ribonuclease conjugates as cytotoxic agents | QUINTESSENCE BIOSCIENCES, INC. (US) | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170000859-A1 | NON-NATURAL RIBONUCLEASE CONJUGATES AS CYTOTOXIC AGENTS | RNASE1, RNASEL, RNASEH1 | CYP1A2 4410/4885CYP3A4 4461/4885MAOA 3586/4885 |
| US-20240150452-A1 | MULTIFUNCTIONAL PROTEIN MOLECULES COMPRISING DECORIN AND USE THEREOF | CD2BP2, DSTN, SDCBP | CYP1A2 4879/4885CYP3A4 4883/4885MAOA 3138/4885 |
| US-11879009-B2 | Multifunctional protein molecules comprising decorin and use thereof | CD2BP2, DSTN, SDCBP | CYP1A2 4879/4885CYP3A4 4883/4885MAOA 3138/4885 |
| US-11377488-B2 | Multifunctional protein molecules comprising decorin and use thereof | CD2BP2, DSTN, SDCBP | CYP1A2 4879/4885CYP3A4 4883/4885MAOA 3138/4885 |
| US-20140017241-A1 | NON-NATURAL RIBONUCLEASE CONJUGATES AS CYTOTOXIC AGENTS | RNASE1, RNASEL, RNASEH1 | CYP1A2 4410/4885CYP3A4 4461/4885MAOA 3586/4885 |
| US-20050261232-A1 | Non-natural ribonuclease conjugates as cytotoxic agents | RNASE1, RNASEL, RNASEH1 | CYP1A2 4410/4885CYP3A4 4461/4885MAOA 3586/4885 |
| US-20140212946-A1 | NON-NATURAL RIBONUCLEASE CONJUGATES AS CYTOTOXIC AGENTS | RNASE1, RNASEL, RNASEH1 | CYP1A2 4410/4885CYP3A4 4461/4885MAOA 3586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.